Mercer Global Advisors’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.24M Buy
11,554
+136
+1% +$8.91K ﹤0.01% 1610
2026
Q1
$90.3K Buy
11,418
+6,420
+128% +$104K ﹤0.01% 3040
2025
Q4
$86.1K Buy
+4,998
New +$96.9K ﹤0.01% 2737

Other funds holding AGL

Mercer Global Advisors's AGL Position: Q2 2026 in Review

Mercer Global Advisors increased its Agilon Health (AGL) stake by 1.2% in Q2 2026, buying an estimated $8.91K and bringing the position to 11,554 shares worth $1.24M. The position accounts for ﹤0.01% of the portfolio, ranked #1610.

Mercer Global Advisors first reported a position in AGL in Q4 2025 and has held it in 3 quarters since. 179 funds tracked by Wall St. Rank hold AGL as of Q2 2026.

  • Mercer Global Advisors held 11,554 shares of Agilon Health worth $1.24M as of Q2 2026.
  • Mercer Global Advisors bought 136 Agilon Health shares in Q2 2026, an estimated $8.91K.
  • Agilon Health made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #1610 holding.
  • Mercer Global Advisors first reported a position in Agilon Health in Q4 2025 and has held it in 3 quarters since.
  • 179 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.